Cardiovascular improvements with minute ventilation-targeted adaptive servo-ventilation (MV-ASV) therapy in heart failure.

22 May 2016 (08:30 - 08:37)

Organised by:

Video

Sign in for access options

Slides

About the speaker

Doctor Christopher O'Connor

Inova Heart and Vascular Institute, Washington, DC (United States of America)

11 More presentations in this session

Presentation thumbnail

Discussion: minute ventilation-targeted adaptive servo-ventilation.

Presentation thumbnail

Transvenous phrenic nerve stimulation for central sleep apnea.

Doctor M. Costanzo (Naperville, US)

Presentation thumbnail

Discussion: Transvenous phrenic nerve stimulation for central sleep apnea.

Presentation thumbnail

Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in chronic heart failure patients with and without diabetes.

Doctor A. Jorsal (Aarhus, DK)

Presentation thumbnail

Discussion: Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in chronic heart failure patients with and without diabetes.

Access the full session

Session thumbnail

Late Breaking Trials II: Focus on chronic heart failure

The Event

HEART FAILURE 2016

22 May 2016 08:30 CET

You may be interested in

Congress Presentation

Treating sleep disordered breathing in heart failure.

23 May 2022

Congress Presentation

Chemosensitivity and its association with exercise ventilation inefficiency in patients with chronic coronary syndromes compared to heart failure

25 April 2024

Congress Session

Emerging interventional procedures in heart failure and pulmonary hypertension

20 May 2025

Congress Session

Devices in acute heart failure

19 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources